BridgeMD
New treatment option for Pain
Official title Evaluation of Pain Treatment After Total Knee Arthroplasty
ClinicalTrials.gov ID: NCT07538570
What this study is testing
What is Suzetrigine?
Suzetrigine is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for pain.
Also referred to as VX-548, JOURNAVX.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2)
- Scheduled to undergo an elective primary unilateral TKA surgery Key
You likely can't join if
- \- History of previous TKA surgery on incident side
- Other protocol defined Inclusion/Exclusion criteria will apply.
The study team makes the final eligibility decision.
Where it's taking place
- Bellaire, Texas, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bellaire, Texas, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.